Evolus Inc (EOLS)
Evolus - Evolysse™ Recognized in 2025 Shape Skin Awards
Evolus - Evolysse™ Recognized in 2025 Shape Skin Awards
Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
Transactions in Connection with Share Buy-back Program
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
Replace - Annual General Meeting :: Voluntary
Zepzelca® (lurbinectedin) and Atezolizumab(Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer
Guardant Health, Inc. - Guardant Health Wins FastCompany’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
Citius Pharmaceuticals, Inc. - Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention